Recherche avancée
Affichage des résultats 1421 à 1440 sur 6833 au total
-
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
R. Boussageon, François Gueyffier, Catherine Cornu
-
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
M. Lapeyre-Mestre, C. Sapède, N. Moore, P. Bilbault, P. Blin, D. Chopy, D. Evans, François Gueyffier, L. Lacoin, M. Malbezin, J. Micallef, D. Morlet-Vigier, S. Muller, E. Oger, Y. Plétan, Gérard Pons, P. Verpillat, C. Vigneau
-
Correspondance à propos de l\textquoterightarticle \guillemotleft Objectifs glycémiques dans la prise en charge du diabète de type 2 \guillemotright
R. Boussageon, François Gueyffier, C. Cornu
-
Clinically Relevant Efficacy of Insulin Therapy in Patients with Type 2 Diabetes
R. Boussageon, J. M. Gamble, François Gueyffier, C. Cornu
-
Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality
Sylvie Erpeldinger, Laure Fayolle, Rémy Boussageon, Marie Flori, Xavier Lainé, Moreau Alain, François Gueyffier
-
Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
M. Al-Gobari, C. El Khatib, F. Pillon, François Gueyffier
-
Revising the ECRIN standard requirements for information technology and data management in clinical trials.
Christian Ohmann, Steve Canham, Catherine Cornu, Jochen Dress, François Gueyffier, Wolfgang Kuchinke, Enrico Nicolis, Michael Wittenberg
-
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, Pascal Bilbault, Patrick Blin, Damien Chopy, David Evans, François Gueyffier, Laure Lacoin, Muriel Malbezin, Joëlle Micallef, Dana Morlet-Vigier, Sophie Muller, Emmanuel Oger, Yannick Plétan, Gérard Pons, Patrice Verpillat, Caroline Vigneau
-
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
D. Dobre, J. S. Borer, K. Fox, K. Swedberg, K. F. Adams, J. G. Cleland, A. Cohen-Solal, M. Gheorghiade, François Gueyffier, C. M. O'Connor, M. Fiuzat, A. Patak, I. L. Pina, G. Rosano, H. N. Sabbah, L. Tavazzi, F. Zannad
-
Apport de la modélisation et des populations virtuelles pour transposer les résultats des essais cliniques à la vie réelle et éclairer la décision publique
François Gueyffier, C. B. Strang, G. Berdeaux, L. R. França, P. Blin, J. Benichou, J. Massol
-
Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial
C. Scholtes, P. Andre, C. Trepo, C. Cornu, Laurent Remontet, René Ecochard, Théodora Bejan-Angoulvant, François Gueyffier
-
Traitement anti-hypertenseur et tabac
R. Boussageon, G. Grand, François Gueyffier
-
The IDEAL Study : Towards Personalized Drug Treatment of Hypertension
T. Bejan-Angoulvant, J-P. Baguet, S. Erpeldinger, J-M. Boivin, A. Mercier, G. Leftheriotis, J-P. Gagnol, J-P. Fauvel, C. Giraud, G. Bricca, François Gueyffier
-
Virtual Patients and Sensitivity Analysis of the Guyton Model of Blood Pressure Regulation: Towards Individualized Models of Whole-Body Physiology
R. Moss, T. Grosse, I. Marchant, N. Lassau, François Gueyffier, S. R. Thomas
-
Impact of the early reduction of cyclosporine on renal function in heart transplant patients: a French randomised controlled trial.
Pascale Boissonnat, Ségolène Gaillard, Catherine Mercier, Michel Redonnet, Bernard Lelong, Marie-Françoise Mattei, Annick Mouly-Bandini, Sabine Pattier, Agnès Sirinelli, Eric Epailly, Shaida Varnous, Marc-Alain Billes, Laurent Sebbag, René Ecochard, Catherine Cornu, François Gueyffier
-
Efficacy of a home-based intervention programme on the physical activity level and functional ability of older people using domestic services: A randomised study
M. Bonnefoy, F. Boutitie, Catherine Mercier, François Gueyffier, C. Carre, G. Guetemme, B. Ravis, M. Laville, C. Cornu
-
Pharmacotherapy for mild hypertension (Review)
D. Diao, Jm. Wright, Dk. Cundiff, François Gueyffier
-
Modeling the impact of cardiovascular prevention strategies: toward better information for public health decisions
François Gueyffier, I. Marchant, B. Carlberg
-
Individual patient data meta-analysis of survival data using Poisson regression models.
Michael Crowther, Richard Riley, Jan Staessen, Jiguang Wang, Francois Gueyffier, Paul Lambert
-
Contribution of modeling approaches and virtual populations in transposing the results of clinical trials into real life and in enlightening public health decisions
François Gueyffier, Cb. Strang, G. Berdeaux, Lr. Franca, P. Blin, J. Massol